News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 143305

Tuesday, 06/05/2012 7:27:49 PM

Tuesday, June 05, 2012 7:27:49 PM

Post# of 257253
Tough day for ThromboGenics and BioInvent—in addition to the failure and program termination of TB-402 (#msg-76294033), former partner Roche dumped TB-403, a cancer drug targeting PIGF:

http://finance.yahoo.com/news/thrombogenics-bioinvent-regain-full-rights-053200538.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now